Products D1000078 + D1000082 + D1000083 + D1000085
D1000078 + D1000082 + D1000083 + D1000085 Phase 1 Completed 💤 Quiet Magnetic Marker Monitoring
Magnetic Marker Monitoring, Gastrointestinal-transport, Gastric Emptying Time, Small Intestinal Transit Time, Time for Colon Arrival, Food Effect
Oct 1, 2010 → Nov 1, 2010
About D1000078 + D1000082 + D1000083 + D1000085 D1000078 + D1000082 + D1000083 + D1000085 is a phase 1 stage product being developed by AstraZeneca for Magnetic Marker Monitoring. The current trial status is completed. This product is registered under clinical trial identifier NCT01224587. Target conditions include Magnetic Marker Monitoring, Gastrointestinal-transport, Gastric Emptying Time.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT01224587 Phase 1 Completed Oct 1, 2010 Nov 1, 2010 Magnetic Marker Monitoring
Product Company Stage Hype Score HRS-9231 + Gadobutrol Jiangsu Hengrui Medicine Phase 2 Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Pre-clinical Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882) Bayer Phase 3 Gadoquatrane (BAY1747846) Bayer Phase 3 Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) Bayer Phase 2 GBCAs Bayer Pre-clinical Gadobutrol (Gadovist, BAY86-4875) Bayer Phase 3 BAY1747846 Bayer Phase 1 Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Approved Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + Gadoteridol Bayer Phase 3 Gadobutrol (Gadovist, BAY86-4875) Bayer Pre-clinical Gadopentetate dimeglumine (Magnevist, BAY86-6661) Bayer Phase 3 Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + Gadoteridol Bayer Phase 3 Gadobutrol (Gadavist, Gadovist, BAY86-4875) Bayer Phase 1 Gadobutrol (Gadovist, BAY86-4875) Bayer Pre-clinical Gadobutrol (Gadavist, BAY86-4875) Bayer Phase 1 BAY1747846 + Matching placebo Bayer Phase 1 Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placebo Bayer Phase 1 Gadobutrol (Gadavist/Gadovist, BAY86-4875) Bayer Pre-clinical Gadoxetate disodium (Eovist/Primovist, BAY86-4873) Bayer Phase 3
Other Products from AstraZeneca